At the beginning of 2010 we offered you an idea about the asset class we thought should do best over the next ten years. Japanese equities, we said, would be the “trade of the decade”. At the time they were, as Merryn pointed out, unloved, unfashionable, underowned and undervalued. The Nikkei 225 traded on a average price-to-book (p/b) value of about one. That’s cheap. We didn’t expect it to go nuts in a year but we were convinced (as we usually are) that value always outs and that Japan would be a very good long-term investment. It has been. The Nikkei is up around 200% since. That hasn’t made it the trade of the decade. The Dow Jones is up around the same and the Nasdaq by 450%. But it’s not a bad return at all.
So what should be the trade of the decade this time (I know we’ve missed the beginning of the year, but the decade is still young)? The answer could be the market that is as unloved, unfashionable, under-owned and relatively cheap as Japan was ten years ago. Yes it is the FTSE 100, or more precisely, UK large-cap value stocks. As a team at US asset manager Research Affiliates points out, after years of outperformance from growth stocks, value stocks now trade at “extremely deep discounts” globally – whichever valuation method you use. But nowhere is this more pronounced than in the UK, which was not only the worst-performing major stock market overall last year, but where value stocks specifically (as measured by those with the lowest p/b ratio) fell by 15%.
Why is the UK so detested? I think you can guess. Brexit uncertainty (would we ever get a deal? If so, what would it look like?) has hung over the market since we voted to leave the European Union in 2016, while as recent GDP figures for 2020 revealed, we were also among the economies worst hit by the Covid-19 pandemic. As a result, according to Research Affiliates, “UK equities are now trading at valuation levels comparable to emerging markets”. Of course, the big difference “is that the UK is a developed market with a sophisticated economy”.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
So is the UK a value trap? Or a bargain? Well, with a Brexit deal behind us, much of the uncertainty is now gone, and “the Armageddon scenarios envisioned by many on the ‘remain’ side of the debate never materialised”. As for the pandemic, the UK “is among the world’s champions in leading the Covid-19 vaccination charge”. So two of the biggest negatives for the UK market are now gone, even though much of the discount remains. Add it all up, and “UK stocks should be especially attractive”, with an estimated ten-year real (after-inflation) return of around 6% a year, compared with projected small losses for US equities (and around 3.5% positive real returns a year for Japan, since you ask).
How can you play this? The good news is that it’s not hard. A simple FTSE tracker fund will give you the exposure you need, nice and cheaply. If you want to invest in value more specifically, one option might be to take another look at the Temple Bar Investment Trust (LSE: TMPL). The trust has had a particularly tough few years precisely because of its value focus, but despite a change of management, the value angle remains, it trades on a discount of about 8%, and the portfolio is full of precisely the sorts of large-cap value stocks that look so cheap right now.
-
Hargreaves Lansdown slashes fees for ISA and SIPP investors - how does it compare to other providers?Hargreaves Lansdown, the UK’s biggest investment platform, has dropped its fees by 40%, to their lowest ever level, for certain customers. Is it a good deal, and how does it compare to other providers?
-
BP's 'long, painful decline' – and why next year could be even tougherOpinion Long-suffering shareholders in oil giant BP have been pushing for change. It won’t come soon enough, says Matthew Lynn
-
BP's 'long, painful decline' – and why next year could be even tougher
Opinion Long-suffering shareholders in oil giant BP have been pushing for change. It won’t come soon enough, says Matthew Lynn
-
Investment trusts tap the profits in exotic and obscure global marketsOpinion Peter Walls, manager of the Unicorn Mastertrust fund, highlights three investment trusts as he shares where he'd put his money
-
Falling revenues and mounting debt spell trouble for Jumia TechnologiesStruggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
-
Next reports £1 billion in annual profits for the first time – what's next for the retailer?Clothing retailer Next has become only the fourth member of its sector to surpass £1 billion in annual profits. What does this mean for the company's future?
-
Best of British bargains: cash in on undervalued companies in the UK stock marketOpinion Michael Field, Chief Equity Market Strategist, EMEA, Morningstar, selects three attractive UK stocks where he'd put his money
-
Building firm Keller presents low debt and ample scope for growthGeotechnical contractor Keller, which supports vital global infrastructure, boasts rising profits and a cheap valuation
-
PZ Cussons share price down 75% in last decade – why it's one to watchOpinion Once-strong consumer-goods business PZ Cussons is out of favour with the market. That spells opportunity for investors, says Jamie Ward
-
Cash in on the biotech sector with specialist trust BioPharmaOpinion BioPharma has an attractive niche in lending to asset-rich biotechnology companies
